Thymomas are tumors of the thymus and are benign in around 75% of cases. A quarter of thymomas are malignant – they are divided into malignant thymomas and thymic carcinomas depending on the appearance and degree of differentiation of the diseased cells and their tendency to spread [1,3,4]. At 0.2-1.5% of all human malignancies in German-speaking countries and 1.7/1,000,000 in Europe, they account for a very small proportion.
Autoren
- Dr. med. Hans-Joachim Thiel
Publikation
- InFo ONKOLOGIE & HÄMATOLOGIE
Related Topics
You May Also Like
- Advanced Thyroid Cancer
Molecular Mechanisms and New Therapeutic Approaches
- Epidermolysis bullosa
Promoting Wound Healing with Gene Therapies and Birch Bark Extract
- From Risk Identification to Anti-Inflammatory Intervention
Inflammation as a Treatment Goal in Its Own Right
- Psoriasis Research: What's in the Pipeline?
Highly selective oral TYK inhibitors in Phase III
- Cardiometabolism
Retatrutid and the TRIUMPH Program: The Triple Agonist on the Horizon
- Pediatric Retinoblastoma
The Tumor Microenvironment and Modern Eye-Sparing Therapies
- Adherence and management in asthma and COPD
Better to listen to the pharmacist
- Focus Update 2026